Literature DB >> 20101476

In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue.

Salina M Torres1, Thomas H March, Meghan M Carter, Consuelo L McCash, Steven K Seilkop, Miriam C Poirier, Dale M Walker, Vernon E Walker.   

Abstract

The current study was designed to delineate temporal changes in cardiomyocytes and mitochondria at the light and electron microscopic levels in hearts of mice exposed transplacentally to commonly used nucleoside analogs (NRTIs). Pregnant CD-1 mice were given 80 mg AZT/kg, 40 mg 3TC/kg, 80 mg AZT/kg plus 40 mg 3TC/kg, or vehicle alone during the last 7 days of gestation, and hearts from female mouse pups were examined at 13 and 26 weeks postpartum for histopathological or ultrastructural changes in cross-sections of both the ventricles and the interventricular septum. Using light microscopy and special staining techniques, transplacental exposure to AZT, 3TC, or AZT/3TC was shown to induce significant histopathological changes in myofibrils; these changes were more widespread at 13 weeks than at 26 weeks postpartum. While most light microscopic lesions resolved, some became more severe between 13 and 26 weeks postpartum. Transplacental NRTI exposure also resulted in progressive drug-specific changes in the number and ultrastructural integrity of cardiac mitochondria. These light and electron microscopic findings show that a subset of changes in cardiac mitochondria and myofibrils persisted and progressed months after transplacental exposure of an animal model to NRTIs, with combined AZT/3TC exposure yielding additive effects compared with either drug alone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101476      PMCID: PMC2867104          DOI: 10.1007/s12012-010-9061-3

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  38 in total

Review 1.  Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions.

Authors:  William Lewis
Journal:  Antiviral Res       Date:  2003-05       Impact factor: 5.970

Review 2.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors.

Authors:  Vernon E Walker; Miriam C Poirier
Journal:  Environ Mol Mutagen       Date:  2007 Apr-May       Impact factor: 3.216

Review 4.  Genetic risks of antiviral nucleoside analogues--a survey.

Authors:  P Wutzler; R Thust
Journal:  Antiviral Res       Date:  2001-02       Impact factor: 5.970

5.  Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma.

Authors:  S E Lim; W C Copeland
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

6.  Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS.

Authors:  William Lewis; Chad P Haase; Yoon K Miller; Brandy Ferguson; Tami Stuart; Tomika Ludaway; Jamie McNaught; Rodney Russ; Jeffrey Steltzer; Robert Santoianni; Robert Long; Giuseppe Fiermonte; Ferdinando Palmieri
Journal:  Lab Invest       Date:  2005-08       Impact factor: 5.662

Review 7.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

Authors:  T N Kakuda
Journal:  Clin Ther       Date:  2000-06       Impact factor: 3.393

8.  Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice.

Authors:  W Lewis; C P Haase; S M Raidel; R B Russ; R L Sutliff; B D Hoit; A M Samarel
Journal:  Lab Invest       Date:  2001-11       Impact factor: 5.662

9.  Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

Authors:  O A Olivero; L M Anderson; B A Diwan; D C Haines; S W Harbaugh; T J Moskal; A B Jones; J M Rice; C W Riggs; D Logsdon; S H Yuspa; M C Poirier
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

10.  Mitochondrial damage revealed by morphometric and semiquantitative analysis of mouse pup cardiomyocytes following in utero and postnatal exposure to zidovudine and lamivudine.

Authors:  Jack B Bishop; Yoshiro Tani; Kristine Witt; Jo Anne Johnson; Shyamal Peddada; June Dunnick; Abraham Nyska
Journal:  Toxicol Sci       Date:  2004-06-30       Impact factor: 4.849

View more
  7 in total

1.  Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Authors:  Steven E Lipshultz; William T Shearer; Bruce Thompson; Kenneth C Rich; Irene Cheng; E John Orav; Sulekha Kumar; Ricardo H Pignatelli; Louis I Bezold; Philip LaRussa; Thomas J Starc; Julie S Glickstein; Sharon O'Brien; Ellen R Cooper; James D Wilkinson; Tracie L Miller; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

2.  Reduced diastolic function and left ventricular mass in HIV-negative preadolescent children exposed to antiretroviral therapy in utero.

Authors:  W Todd Cade; Alan D Waggoner; Sara Hubert; Melissa J Krauss; Gautam K Singh; E Turner Overton
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

3.  In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue.

Authors:  Salina M Torres; Rao L Divi; Dale M Walker; Consuelo L McCash; Meghan M Carter; Matthew J Campen; Tracey L Einem; Yvonne Chu; Steven K Seilkop; Huining Kang; Miriam C Poirier; Vernon E Walker
Journal:  Cardiovasc Toxicol       Date:  2010-06       Impact factor: 3.231

4.  Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.

Authors:  Steven E Lipshultz; Paige L Williams; James D Wilkinson; Erin C Leister; Russell B Van Dyke; William T Shearer; Kenneth C Rich; Rohan Hazra; Jonathan R Kaltman; Denise L Jacobson; Laurie B Dooley; Gwendolyn B Scott; Nicole Rabideau; Steven D Colan
Journal:  JAMA Pediatr       Date:  2013-06       Impact factor: 16.193

5.  Cardiac status of perinatally HIV-infected children: assessing combination antiretroviral regimens in observational studies.

Authors:  Paige L Williams; Katharine Correia; Brad Karalius; Russell B Van Dyke; James D Wilkinson; William T Shearer; Steven D Colan; Steven E Lipshultz
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

6.  Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine.

Authors:  Anna Rita Zuena; Chiara Giuli; Aldina Venerosi Pesciolini; Antonella Tramutola; Maria Antonietta Ajmone-Cat; Carlo Cinque; Giovanni Sebastiano Alemà; Angela Giovine; Gianfranco Peluso; Luisa Minghetti; Raffaella Nicolai; Gemma Calamandrei; Paola Casolini
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

7.  In utero exposure to diesel exhaust air pollution promotes adverse intrauterine conditions, resulting in weight gain, altered blood pressure, and increased susceptibility to heart failure in adult mice.

Authors:  Chad S Weldy; Yonggang Liu; H Denny Liggitt; Michael T Chin
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.